Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
What is the chemical name of a drug mean?
|
Name the medicinal chemist uses to refer to it.
|
|
What is the code name?
|
Chosen by manufacturer during drug development usually are unaware of the drug name?
|
|
What is the proprietary name?
|
Also chosen by the manufacturer for marketing purposes..also referred to as brand or trade name
|
|
Official name
|
assigned by the US Adopted Name Council
|
|
Generic name
|
Offical, nonproprietary name
used after patent loss |
|
What are some of the physiochemical properties of drug molecules?
|
Small MW..stability in vitro and in vivo
solubillity in H2O and oil 3-D structure ionizable groups |
|
What is Lipophilicity?
|
Solubility in lipid relative to water
Measured by oil/water partition coefficient * ability a drug has to diffuse into cell |
|
What is Pharmacodynamics?
|
Study of biologic effects produced by chemicals, the site at which and mechanism by which the biologic effects are produced ; the fate of a chemical agent in the body: its absorption, distribution, elimination, and the factors which influence the safety and effectiveness of an agent.
|
|
What is Pharmacokinetics?
|
The time course of:
absorption distribution elimination Factors that modify pharmacokinetic phenomenon |
|
What are the objectives of PK analysis?
|
predict time course of drug effect
predict concentration at site of action characterize absorption, distribution, elimination kinetics dose/species dependence |
|
What are the four types of biotransport?
|
passive diffusion
filtration carrier-mediated transport receptor-mediated endocytosis |
|
Explain passive diffusion
|
Passage through lipid cell membrane by dissolution in membrane
*rate dependent of concentration gradient *obeys first-order kinetics |
|
Explain filtration
|
Transport of substance in bulk flow of aqueous fluid
*Rate dependent on: -hydrostatic pressure -mw, size, charge, and binding to excluded macromolecules -tissue porosity |
|
Explain carrier-mediated transport
|
involves saturable kinetics, substrate competition, and tissue differences in expression of carriers
|
|
What are two types of drug transporters
|
Multidrug resistance p-glycoproteins
Mulidrug restistance associated proteins |
|
What is the MDR p-Gylcoprotein?
|
PM protein that can pum drugs inside the cell out...
Why cancerous cells stop responding to chemotherapy. |
|
Drug transporters are usually located?
|
Intestinal mucosa
hepatocyte proximal renal tube brain: choroid plexus, vascular endothelium |
|
What is receptor mediated endocytosis?
|
Internalization into PM
Important in selective tissue uptake Rate dependent of receptor expression and membrane insertion Saturable kinetics |
|
What is absorption kinetics?
|
Time between absorption and distribution
Characterization by: half-life percent dose absorbed (bioavailabililty) |
|
Describe route of administration intravenously
|
100% bioavilability---all of dose in plasma compartment
rate dependent on technique importance of sterility |
|
Describe route of administration subcutaneously
|
-Uptake of high mw cmps into lymphatics
absorption is slow -blood flow is rate-limiting factor for some drugs -improved bioavailability over oral route for some drugs |
|
Describe route of administration inhalation
|
rapid absorption of gases and vapors due to:
-high pulmonary blood flow -low diffusional distance from avelous to blood -route for localized delievery of drugs with actions in pulmonary tissue |
|
describe route of topical administration
|
absorption through skin slow due to surface layers of dead, keratinized cells
-drugs with sufficeint lipophilicity and potency may have systemic clinical efficacy upon topical application in transdermal patch |
|
What is enteral administration?
|
pertains to administratin of drugs into any part of the gastrointenstinal tract..oral, sublingual, rectal
|
|
Describe the route of oral administration
|
Bioavailiability may be low due to: mucosa as barrier
or first pass effect: absorbed drug passes via portal circulation through liver which may clear substantial fraction and thus decresase bioavailability... |
|
Two important factors of absorption are:
|
half-life
bioavailability |